艾吉纳斯公司(AGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AGEN 艾吉纳斯公司

交易中 08-20 10:09:06 EDT

7.86

-0.40

-4.84%

最高8.25	最低7.81	成交量24.70万
今开8.22	昨收8.26	日振幅5.33%
总市值3.54亿	流通市值3.32亿	总股本4,502万
成交额198.75万	换手率0.59%	流通股本4,221万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AGEN","market":"US","secType":"STK","nameCN":"艾吉纳斯公司","latestPrice":7.86,"timestamp":1787234938071,"preClose":8.26,"halted":0,"volume":247005,"delay":0,"changeRate":-0.04842615012106531,"floatShares":42205859,"shares":45020400,"eps":2.500181,"marketStatus":"交易中","change":-0.4,"latestTime":"08-20 10:09:06 EDT","open":8.22,"high":8.25,"low":7.81,"amount":1987477.31952,"amplitude":0.053269,"askPrice":7.87,"askSize":10,"bidPrice":7.85,"bidSize":181,"shortable":3,"etf":0,"ttmEps":2.500181,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787256000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":949640400000,"exchange":"NASDAQ","adjPreClose":8.26,"preHourTrading":{"tag":"盘前","latestPrice":8.14,"preClose":8.26,"latestTime":"09:25 EDT","volume":2456,"amount":20016.4614,"timestamp":1787232300017,"change":-0.12,"changeRate":-0.014528,"amplitude":0.089588},"postHourTrading":{"tag":"盘后","latestPrice":8.48,"preClose":8.26,"latestTime":"19:57 EDT","volume":21342,"amount":176572.8221,"timestamp":1787183855420,"change":0.22,"changeRate":0.026634,"amplitude":0.031477},"volumeRatio":2.018269,"impliedVol":0.9608,"impliedVolPercentile":0.502},"requestUrl":"/m/hq/s/AGEN/tweets","defaultTab":"tweets","newsList":[{"id":"1116407663","title":"艾吉纳斯公司贷款本金2475万美元，到期日延长至2029年11月30日，年利率13.0%——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1116407663","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116407663?lang=zh_cn&edition=full","pubTime":"2026-08-19 04:33","pubTimestamp":1787085188,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司（Agenus）在最新提交给美国证券交易委员会（SEC）的文件中披露，其贷款本金为2475万美元，到期日已延长至2029年11月30日，年利率为13.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195079559","title":"艾吉纳斯公司公布2026年第二季度业绩，推进BOT+Bal联合疗法在MSS结肠癌新辅助治疗中的3期Robbin试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1195079559","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195079559?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:31","pubTimestamp":1786015918,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司（Agenus）近日披露了2026年第二季度的财务成果，并同步更新了其关键临床研究——针对微卫星稳定型（MSS）结肠癌新辅助治疗，采用BOT+Bal联合方案的3期Robbin试验，正稳步推进中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113443417","title":"艾吉纳斯公司将在2026年ESMO大会上展示三项BOT+Bal方案研究，覆盖新辅助/后线结直肠癌及晚期肉瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1113443417","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113443417?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:30","pubTimestamp":1784298600,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司（Agenus）宣布，其BOT+Bal联合治疗方案将在2026年欧洲肿瘤内科学会（ESMO）年会上进行三项数据展示。这些报告将涵盖该疗法在多个难治性肿瘤领域的应用探索。\n具体而言，展示内容将涉及新辅助治疗及后线治疗场景下的结直肠癌，以及晚期肉瘤患者群体。这些数据有望揭示BOT+Bal方案在不同疾病阶段和肿瘤类型中的潜力与临床价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198173192","title":"艾吉纳斯公司宣布超额认购至多3.4亿美元私募，以推进BOT+Bal新辅助治疗MSS结肠癌的注册性Robbin试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1198173192","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198173192?lang=zh_cn&edition=full","pubTime":"2026-07-13 18:01","pubTimestamp":1783936884,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司宣布，其一项至多3.4亿美元的私募融资获得超额认购。此次融资旨在推进其BOT+Bal联合疗法作为新辅助治疗，用于微卫星稳定型结肠癌患者的注册性Robbin临床试验。\n该笔资金将直接用于支持关键性试验的开展，标志着公司核心管线向前迈出了重要一步。市场对此次融资反应积极，显示出投资者对该疗法潜力的信心。此举有望加速该创新疗法的发展进程，为患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185330474","title":"艾吉纳斯公司在ESMO GI 2026公布里程碑式BOT+Bal数据：无活动性肝转移的难治性MSS转移性结直肠癌患者三年总生存率达33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185330474","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185330474?lang=zh_cn&edition=full","pubTime":"2026-07-06 19:30","pubTimestamp":1783337447,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司于2026年欧洲肿瘤内科学会胃肠道肿瘤大会（ESMO GI 2026）上公布了一项具有里程碑意义的BOT+Bal联合疗法数据。数据显示，在无活动性肝转移的难治性微卫星稳定（MSS）转移性结直肠癌患者群体中，该疗法实现了33%的三年总生存率。这一结果凸显了该疗法在治疗这一极具挑战性的癌症亚型方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136075862","title":"艾吉纳斯公司公布2026年第一季度财报，并强调BOT+Bal在全球可及性与三期开发中的执行进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1136075862","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136075862?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:47","pubTimestamp":1778503624,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司公布了其2026年第一季度的财务业绩。公司同时重点介绍了其BOT+Bal（博替利单抗+巴利昔单抗）组合疗法在全球可及性计划以及关键三期临床试验开发方面的执行情况。\n财务业绩的公布为评估公司当前运营状况提供了基准。而将焦点置于BOT+Bal的执行进展，则突显了公司对该核心资产在商业化路径和晚期临床验证阶段推进的战略重视。全球可及性工作的推进，旨在为该疗法未来潜在的市场覆盖奠定基础；同时，三期开发阶段的扎实执行，对于验证其疗效与安全性、并最终满足监管要求至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168585639","title":"艾吉纳斯公司公布II期研究数据：BOT/BAL联合AGENT-797治疗PD-1难治性胃食管癌结果将亮相2026年AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=1168585639","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168585639?lang=zh_cn&edition=full","pubTime":"2026-04-03 19:31","pubTimestamp":1775215886,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司宣布，其BOT/BAL联合AGENT-797治疗PD-1难治性胃食管癌的II期研究数据，将于2026年美国癌症研究协会（AACR）年会上正式公布。\n该研究旨在评估这一创新组合疗法针对PD-1抑制剂治疗无效的胃食管癌患者的潜力。相关数据的发布备受业界关注，有望为这类难治性癌症患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193741392","title":"艾吉纳斯公司宣布首例患者入组全球三期Battman试验：BOT+Bal免疫疗法组合用于MSS或pMMR转移性结直肠癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193741392","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193741392?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:30","pubTimestamp":1775043026,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司（Agenus）宣布，其全球三期Battman试验已完成首例患者入组。该试验旨在评估BOT与Bal免疫疗法联合用药方案，针对微卫星稳定（MSS）或错配修复正常（pMMR）的转移性结直肠癌患者的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618573329","title":"艾吉纳斯盘中异动 股价大涨5.24%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618573329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618573329?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:34","pubTimestamp":1773149651,"startTime":"0","endTime":"0","summary":"北京时间2026年03月10日21时34分，艾吉纳斯股票出现波动，股价大幅拉升5.24%。截至发稿，该股报3.32美元/股，成交量5.6462万股，换手率0.16%，振幅1.90%。艾吉纳斯股票所在的生物技术行业中，整体涨幅为1.50%。其相关个股中，Mink Therapeutics, Inc.、Biorestorative Therapies, Inc.、Tenax Therapeutics, Inc.涨幅较大，Biorestorative Therapies, Inc.、Mink Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为543.77%、217.33%、144.83%，振幅较大的相关个股有Tenax Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Acurx Pharmaceuticals, Inc.，振幅分别为16.52%、15.57%、15.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031021341197ac198b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031021341197ac198b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145345939","title":"艾吉纳斯公司启动与Zydus Life Sciences合作中的首笔2000万美元或有付款，以支持BOT+Bal的生产需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1145345939","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145345939?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:30","pubTimestamp":1773142215,"startTime":"0","endTime":"0","summary":"艾吉纳斯公司已启动其与Zydus Life Sciences合作协议中的首笔2000万美元或有付款。这笔资金将专项用于支持BOT及Bal组合疗法的生产制造需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137587501","title":"2024年第四季度Agenus GAAP每股收益$(2.04)优于$(2.54)预期，销售额$26.84M低于$30.27M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1137587501","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137587501?lang=zh_cn&edition=full","pubTime":"2025-03-11 19:44","pubTimestamp":1741693481,"startTime":"0","endTime":"0","summary":"Agenus报告称，其季度每股亏损为$，优于分析师一致预期的$，相差19.69%。该季度销售额相比去年同期的$83.80M下降了67.98%。以上内容来自Benzinga Earnings专栏，原文如下：Agenus  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 19.69 percent. This is a 21.54 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $26.84 million which missed the analyst consensus estimate of $30.27 million by 11.35 percent.  This is a 67.98 percent decrease over sales of $83.80 m","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"2024年第四季度Agenus GAAP每股收益$(2.04)优于$(2.54)预期，销售额$26.84M低于$30.27M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516865316","title":"艾吉纳斯盘中异动 股价大跌5.26%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516865316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516865316?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:11","pubTimestamp":1741018306,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时11分，艾吉纳斯股票出现异动，股价急速跳水5.26%。截至发稿，该股报2.70美元/股，成交量13.4252万股，换手率0.57%，振幅6.32%。艾吉纳斯股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3430.66%、150.61%、139.71%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Radiopharm Theranostics Limited，振幅分别为206.20%、70.53%、53.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001146abe65432&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001146abe65432&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514485068","title":"艾吉纳斯盘中异动 临近午盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514485068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514485068?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:30","pubTimestamp":1740587449,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时30分，艾吉纳斯股票出现异动，股价急速上涨5.18%。截至发稿，该股报3.25美元/股，成交量24.3567万股，换手率1.03%，振幅6.80%。艾吉纳斯股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5848.89%、214.53%、211.69%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Organovo Holdings, Inc.，振幅分别为177.12%、49.18%、43.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003050abde0890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003050abde0890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514773785","title":"艾吉纳斯盘中异动 快速下跌5.12%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514773785?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:49","pubTimestamp":1740412172,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时49分，艾吉纳斯股票出现异动，股价快速下挫5.12%。截至发稿，该股报3.15美元/股，成交量12.3481万股，换手率0.52%，振幅9.64%。艾吉纳斯股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为231.05%、97.84%、28.36%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为151.09%、55.69%、53.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234932989107ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234932989107ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513193132","title":"艾吉纳斯盘中异动 下午盘大幅下跌5.07%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513193132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513193132?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:58","pubTimestamp":1740164290,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时58分，艾吉纳斯股票出现异动，股价大幅跳水5.07%。截至发稿，该股报3.28美元/股，成交量16.0683万股，换手率0.68%，振幅6.67%。艾吉纳斯股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为295.35%、247.73%、136.52%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222025810abd7e5e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222025810abd7e5e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511795699","title":"艾吉纳斯盘中异动 早盘快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511795699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511795699?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:47","pubTimestamp":1739544429,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时47分，艾吉纳斯股票出现波动，股价大幅上涨5.14%。截至发稿，该股报3.68美元/股，成交量2.4668万股，换手率0.10%，振幅4.57%。艾吉纳斯股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1778.14%、471.05%、415.00%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422470996231f12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422470996231f12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509403077","title":"艾吉纳斯盘中异动 股价大跌5.08%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509403077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509403077?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:09","pubTimestamp":1738940968,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时09分，艾吉纳斯股票出现异动，股价急速下跌5.08%。截至发稿，该股报3.55美元/股，成交量6.3243万股，换手率0.27%，振幅4.28%。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。艾吉纳斯股票所在的生物技术行业中，整体跌幅为0.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230928abc63379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230928abc63379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509206796","title":"艾吉纳斯盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509206796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509206796?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:28","pubTimestamp":1738859331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时28分，艾吉纳斯股票出现异动，股价大幅跳水5.13%。截至发稿，该股报3.70美元/股，成交量16.394万股，换手率0.69%，振幅8.14%。艾吉纳斯股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Palatin Technologies, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5805.07%、1521.41%、154.12%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Equillium, Inc.，振幅分别为121.32%、53.02%、44.37%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207002852abc4ed39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207002852abc4ed39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509995287","title":"艾吉纳斯盘中异动 股价大涨5.26%报3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509995287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509995287?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:00","pubTimestamp":1738767615,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时00分，艾吉纳斯股票出现波动，股价大幅拉升5.26%。截至发稿，该股报3.68美元/股，成交量11.2095万股，换手率0.47%，振幅4.88%。最近的财报数据显示，该股实现营业收入25.11百万美元，净利润-66.39百万美元，每股收益-3.08美元，毛利21.62百万美元，市盈率-0.33倍。艾吉纳斯股票所在的生物技术行业中，整体涨幅为1.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230015a23a817d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230015a23a817d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507732965","title":"艾吉纳斯盘中异动 早盘股价大涨8.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507732965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507732965?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:31","pubTimestamp":1738333872,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时31分，艾吉纳斯股票出现波动，股价急速拉升8.76%。截至发稿，该股报3.85美元/股，成交量4.4554万股，换手率0.19%，振幅3.11%。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。艾吉纳斯股票所在的生物技术行业中，整体涨幅为0.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013122311298775f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013122311298775f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agenusbio.com","stockEarnings":[{"period":"1week","weight":0.1971},{"period":"1month","weight":0.662},{"period":"3month","weight":1.6139},{"period":"6month","weight":1.6993},{"period":"1year","weight":0.8234},{"period":"ytd","weight":1.6306}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agenus Inc.成立于1994年，是一家特拉华州有限责任公司。该公司是一家临床阶段的生物技术公司，专门开发激活人体免疫系统对抗癌症和感染的疗法。他们的主要临床项目是botensilimab，包括单药治疗和与balstilimab联合治疗。他们还拥有一些处于临床阶段的免疫肿瘤学资产，这些资产可以作为独立药物使用，也可以与botensilimab联合balstilimab联合使用。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.053848},{"month":2,"riseRate":0.346154,"avgChangeRate":0.006143},{"month":3,"riseRate":0.37037,"avgChangeRate":-0.033364},{"month":4,"riseRate":0.518519,"avgChangeRate":0.075072},{"month":5,"riseRate":0.481481,"avgChangeRate":0.035634},{"month":6,"riseRate":0.555556,"avgChangeRate":0.07237},{"month":7,"riseRate":0.518519,"avgChangeRate":0.038959},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.019996},{"month":9,"riseRate":0.192308,"avgChangeRate":-0.071683},{"month":10,"riseRate":0.346154,"avgChangeRate":-0.078113},{"month":11,"riseRate":0.538462,"avgChangeRate":0.045072},{"month":12,"riseRate":0.192308,"avgChangeRate":-0.060665}],"exchange":"NASDAQ","name":"艾吉纳斯公司","nameEN":"Agenus"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾吉纳斯公司(AGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾吉纳斯公司(AGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾吉纳斯公司,AGEN,艾吉纳斯公司股票,艾吉纳斯公司股票老虎,艾吉纳斯公司股票老虎国际,艾吉纳斯公司行情,艾吉纳斯公司股票行情,艾吉纳斯公司股价,艾吉纳斯公司股市,艾吉纳斯公司股票价格,艾吉纳斯公司股票交易,艾吉纳斯公司股票购买,艾吉纳斯公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾吉纳斯公司(AGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾吉纳斯公司(AGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}